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Objectives: This study aims to better understand the relationship between psychosocial 
factors and the development of chronic pelvic pain (CPP) in cases of adolescent 
endometriosis, specifically mood disorders, pain catastrophizing and quality of life, and 
to detect the development of central sensitization within this population.  
Methods: Eligible candidates were patients between 14 and 22 years old with confirmed 
diagnosis of endometriosis and chronic pelvic pain who were enrolled in the Women’s 
Health Study: From Adolescence to Adulthood through the Boston Center for 
Endometriosis (BCE) and Boston Children’s Hospital. The administration of quantitative 
sensory testing (QST) to assess mechanical touch perception, pressure pain sensitivity 
and temporal summation was performed on 48 subjects. Pre-surgical baseline surveys, 
which included pain catastrophizing and quality of life measures, were obtained from the 
BCE. Record of diagnosed mood disorder (anxiety/depression) was obtained through 
medical chart review. Pearson correlations between QST measures, pain catastrophizing, 
presence of mood disorders or central sensitization and pre-surgical pain scores were 
conducted. One-way ANOVA calculations, and one sample and paired t-tests were 




Results: Regarding QST measures, 23 subjects (47.9%) produced a wind-up 
phenomenon from temporal summation during QST administration, which serves as a 
surrogate for the presence of central sensitization (+CS). Pressure sensation and pain 
scores correlated at all test sites (lower and upper abdomen, as well as finger control site) 
and wind-up phenomenon correlated in the lower and upper abdomen throughout the 
cohort. For the presence of mood disorders, anxiety and depression were equally 
distributed across the +CS and –CS groups. Review of pre-surgical pain scores and pain 
catastrophizing (PCS) within the cohort had significant correlations between pre-surgical 
pain and PCS subsets of rumination and magnification. PCS total and subset scores also 
correlated to +CS. One-way ANOVA calculations showed the cohort as a whole 
presented with clinically significant helplessness. 
Conclusions: Results encourage further investigation of the relationship between 
endometriosis, comorbid conditions, environmental factors and the development of CPP 
within the adolescent population. More detailed data regarding mental health and 
documentation of condition progression, as well as establishment of health control values 
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	 Endometriosis, defined as the presence of endometrial-type mucosa outside the 
uterine cavity, is a gynecological disease affecting up to 17% of reproductive-aged 
women (Stuparich, Donnellan, & Sanfilippo, 2017; Vercellini, Viganò, Somigliana, & 
Fedele, 2014). The growth of endometrial tissue, which serves as the site of embryonic 
implantation within the uterine cavity, outside the standard anatomical location, can lead 
to dysmenorrhea, dyspareunia, chronic pelvic pain and infertility (Vercellini et al., 2014). 
Although most commonly diagnosed in adult women, endometriosis is also present in 
postmenarcheal adolescents with similar symptoms including painful or heavy 
menstruation, and bowel and bladder dysfunction (Young, Fisher, & Kirkman, 2017). Of 
note, a study by Stuparich et al. noted that two-thirds of surveyed women diagnosed with 
endometriosis in adulthood presented with symptoms of disease before the age of 20, 
suggesting earlier diagnosis is possible and beneficial (Stuparich et al., 2017). While 
adult cases of endometriosis have a typical cyclic pain presentation, one study found only 
9.4% of adolescents presented with cyclical pain symptoms when surveyed (Marc R 
Laufer, Sanfilippo, & Rose, 2003). The acyclic nature of adolescent symptoms is a 
common cause of delayed diagnosis and can lead to chronic pelvic pain, central 
sensitization, infertility and further disease progression (DiVasta, Vitonis, Laufer, & 




Endometriosis: Symptoms, Diagnosis and Treatment 
The standard approach to confirming a diagnosis of endometriosis is laparoscopic 
investigation with surgical excision of endometrial lesions. Visualization of ectopic 
endometrium is not sufficient for diagnosis (Shin & Howard, 2011). Risk factors for 
disease prior to presentation of dysmenorrhea include family history, early menarche, 
history of asthma, obstructive Mullerian anomalies, and previous surgical history 
(Matalliotakis et al., 2017; Stuparich et al., 2017). In a study of 20 adolescents in New 
Zealand, 30% of participants had confirmed first relatives with an endometriosis 
diagnosis (Roman et al., 2010). Typical presentation in adolescents is mild, with some 
studies finding only stage I and II lesions among participants (M. R. Laufer, Goitein, 
Bush, Cramer, & Emans, 1997). However, a systematic review found that 32% of 
participants in eight of the 15 included studies had moderate to severe endometriosis 
(Janssen, Rijkers, Hoppenbrouwers, Meuleman, & D’Hooghe, 2013). It is clear that 
although symptoms vary, the progression of disease to all stages, including deep 
endometriosis and ovarian endometriomas, is possible within the adolescent population 
and further supports the need for early detection of disease (Saridoğan, 2015).  
Diagnosis of endometriosis during laparoscopic surgery includes the staging of 
disease using the American Society for Reproductive Medicine (ASRM) numerical 
classification system. Using this method, endometriosis can range from stage I (minimal) 
to stage IV (severe) disease. This assessment includes analysis of both extent and depth 
of lesions as well as lesion quality (Doyle, Missmer, & Laufer, 2009). A weighted 
assessment score determines stage of disease, taking into account size (<1cm, 1-3cm, 
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>3cm), type (superficial/deep, filmy/dense), and color (red [red, red-pink, flame-like, 
vesicular blobs, clear vesicles], white [white, yellow-brown, peritoneal defects], or black 
[black and blue lesions]) including percent of each lesion type (American Society for 
Reproductive Medicine, 1997). Photographs and diagrams are provided by the ASRM to 
improve staging accuracy.  
 
Figure 1: American Society for Reproductive Medicine Endometriosis Classification 
Guidelines. Used during laparoscopic procedure to determine stage of endometriosis 
based on type of excised lesions. Stuparich, M. A., Donnellan, N. M., & Sanfilippo, J. S. 




Low levels of pelvic pain associated with menses are commonly treated with 
nonsteroidal anti-inflammatory drugs (NSAIDs). Oral contraceptives are alternatives to 
adverse menstruation symptoms and provide the additional benefit of protection against 
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unwanted pregnancy. Pain that is resistant to these treatment methods should be 
considered suspicious and raise concern for possible presence of endometriosis. It is also 
important to note that even if the standard treatment methods succeed the presence of 
symptoms associated with endometriosis should not be dismissed as further disease 
development is still possible (Saridoğan, 2015). Persistent pelvic pain resistant to 
treatment also supports the need for visual investigation of the abdominal cavity, where a 
diagnosis of endometriosis can be confirmed.  
Although removal of all visualized lesions during the laparoscopic procedure 
should eliminate the presence of symptoms, including pelvic pain, recurrence of 
endometrial lesions is possible. Treatment for lesion recurrence is primarily further 
surgical excision and the adjustment of standard treatment methods (hormonal therapy 
via oral contraceptive or intrauterine device) to match current symptoms. As 
endometriosis is an estrogen-driven disease, the use of gonadotropin releasing hormone 
agonists (GnRHas), which suppress the production of estrogen, is recommended for 
recurrent or severe cases of disease with the hope of slowing lesion growth and reducing 
symptoms. There is concern, however, with the use of GnRHas by adolescent patients 
due to the loss of bone density that accompanies reduced estrogen levels (Zito et al., 
2014). GnRHas also have the risk of side effects, including mood swings/depression and 
substantial weight gain. Similarly, the use of intrauterine devices (IUDs) is not 
recommended in virginal patients, therefore having limited use within the adolescent 
population (Saridoğan, 2015; Zito et al., 2014). Ultimately, the inability to successfully 
	
	 5 
treat pain symptoms related to endometriosis gives concern to the development of 
comorbid conditions, such as anxiety and depression. 
 
Chronic Pelvic Pain as Related to Endometriosis  
The varied presentation of endometriosis-related symptoms in adolescents can 
lead to delayed diagnosis and development of secondary conditions including chronic 
pelvic pain (CPP) (DiVasta et al., 2017). Defined as non-malignant pain sensation in 
structures of the pelvis, CPP must present either continuously or recurrently for longer 
than six months (Baranowski, 2009; Brawn, Morotti, Zondervan, Becker, & Vincent, 
2014). Ahead of pelvic congestion and vulvodynia/vaginitis/vulvar vestibulitis, 
endometriosis is the leading reproductive tract-related cause of and affects almost 40% of 
adolescents with CPP (Stein, 2013; Stuparich et al., 2017; van Aken et al., 2017). Typical 
findings accompanying a diagnosis of CPP include: symptoms present for at least six 
months, incomplete relief despite treatment, significant decrease in physical functioning, 
signs of depression (lack of quality sleep, weight loss, loss of appetite), hypersensitive 
response to nociceptive stimuli and altered family roles (Steege & Siedhoff, 2014). 
Whereas acute pain resolves with treatment and healing of the stimulated area, chronic 
pain is not as clearly understood nor does it respond to a standard treatment plan (Stein, 
2013). As of 2013, it is estimated that 9 million women in the United States between the 




Pain is a subjective experience, making factors like pain catastrophizing, 
characterized by magnification, rumination and exaggerated emotions due to anticipated 
or ongoing pain (Kapoor, Thorn, Bandy, & Clements, 2015; Pielech et al., 2014), and 
pain anxiety important references for understanding pain perception (van Aken et al., 
2017). Driven by Melzack’s Neuromatrix Theory which introduced the idea of 
neuroplasticity, or the concept of experiences shaping the future processing of sensory 
signaling by the central nervous system (Melzack & Katz, 2012), the explanation for 
chronic pelvic pain has expanded to include the development of allodynia, or the 
evolution of pain perception to non-painful stimuli, and the exaggerated reaction to a 
painful stimuli, known as hyperalgesia (Steege & Siedhoff, 2014). Based on this 
expansion of understanding, to define the pain experience as a purely physical 
stimulation is an oversimplification of the pain sensation. Within patients with 
endometriosis, the laparoscopic findings commonly do not correlate to the severity of 
pain reported by the patient, providing further evidence that a singularly physical cause of 
pain is unlikely (Milingos et al., 2006; Steege & Siedhoff, 2014). Another point of 
interest through laparoscopic intervention is the degree of pain level variation reported by 





Figure 2: Melzack’s Neuromatrix Theory of chronic pain. A representation of the 
factors influencing the pain experience and layering of pain signaling within the body 
Melzack, R., & Katz, J. (2012). Pain. Wiley Interdisciplinary Reviews: Cognitive Science, 
4(1), 5. 
 
Assessment of Chronic Pain 
 Understanding the relationship between endometriosis and CPP is necessary to 
improve the treatment of the affected population; however the subjective nature of the 
pain sensation and classification of pain symptoms by researchers impose limitations on 
available testing techniques (Cruz-Almeida & Fillingim, 2014). Based on the current 
hypothesis of pain syndromes, which proposes that different clinical signs reflect unique 
pathophysical origins of pain generation (Rolke et al., 2006), it is believed the work of 
many pain signals from different symptoms come together to produce the unique pain 
characteristics of chronic conditions. Animal model data supports this idea through the 
demonstration of characteristic sensory symptoms produced by multiple mechanical 
stimuli working in harmony (Rolke et al., 2006; C. J. Woolf & Salter, 2000). To bridge 
the mechanism-based hypothesis of pain syndromes from animals to human subjects, the 
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German Research Network on Neuropathic Pain (DFNS) was founded with the goal of 
building a database of neuropathic pain states categorized by patient phenotype, or 
observable characteristics. Using a standardized quantitative sensory testing (QST) 
technique, the DFNS was able to establish baseline parameters for the use of QST on 
patients with neuropathic pain conditions, including chronic pelvic pain (Rolke et al., 
2006).  
 The QST protocol includes seven tests measuring 13 parameters in response to 
sensory stimuli in order to characterize somatosensory functioning (Cruz-Almeida & 
Fillingim, 2014; Rolke et al., 2006). For clinical administration, the tests can be grouped 
as 1) thermal detection thresholds for the perception of cold, warm and paradoxical heat 
sensations, 2) thermal pain thresholds for cold and hot stimuli, 3) mechanical detection 
thresholds for touch and vibration, and 4) mechanical pain sensitivity including 
thresholds for pinprick and blunt pressure, stimulus/response-functions for pinprick 
sensitivity and dynamic mechanical allodynia, and pain summation to repetitive pinprick 
stimuli (wind-up like pain) (Rolke et al., 2006). The QST protocol provides the detection 
and pain thresholds of the participant, which indicates their sensitivity level. Wind-up 
like pain represents increased pain perception to repeated stimuli when compared to 
singular stimuli of the same value in the same location, an indicator of abnormal 
neurological sensory processing known as central sensitization (Rolke et al., 2006). 
 
Central Sensitization 
Central sensitization is the concept that repeated low-level stimuli may result in a 
stronger central perception of pain over time (Steege & Siedhoff, 2014). Discovered and 
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defined by Clifford Woolf, M.B., B.Ch., Ph.D., M.R.C.P., central sensitization (CS) 
develops after peripheral stimulation by noxious stimuli. With time, the spinal cord 
develops a strong, centralized response to normal input from a general region. The 
phenomenon is believed to include both an increase in synaptic strength as well as a 
reduction of inhibitory signaling in the nerves of the spinal cord. In addition to noxious 
stimulation, CS can develop after peripheral inflammation and injury to the spinal cord or 
higher brain center (C. J. Woolf & Salter, 2000). It is also understood to be responsible 
for secondary hyperalgesia, or the spread of increased pain sensitivity to an area beyond 
that of injury, and allodynia, or heightened pain response to light touch stimulation 
(Clifford J. Woolf, 2007). The discovery of CS has allowed new pain treatment methods 
to emerge. Rather than removing the pain stimulus, which proved unsuccessful for cases 
of CS due to centralized versus peripheral changes, the focus has turned to normalizing 




Figure 3: Development of Central Sensitization Phenomenon. Originating from a 
peripheral stimulus, acute central sensitization includes hypersensitivity at the synapse, 
followed by diffuse sensitivity during the late phase of development. Full development of 
central sensitization presents as a loss of sensory inhibition and increased pain 
perception. Woolf, Clifford J. (2007). Central Sensitization Uncovering the Relation 
between Pain and Plasticity. Anesthesiology: The Journal of the American Society of 
Anesthesiologists, 106(4), 866. 
 
The idea of a centralized overreaction to painful stimuli helps explain the 
incorporation of multiple organ systems in the causation of CPP. Peripherally there is no 
sharing of sensory information, however, with central changes a generalized heightened 
response develops, which is thought to generate perceived effects across multiple organ 
systems. Although viewed as a peripheral condition, CPP is clearly associated with 
changes of the central nervous system when compared to a healthy, pain-free population 
(Brawn et al., 2014). Understanding how and why central sensitization appears in certain 
patients and not others is the next step in approaching treatment and prevention strategies 
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for CPP. Symptoms should be treated regardless to origin, as the ability to reverse central 
changes is unknown and pain is thought to exacerbate over time (Brawn et al., 2014).  
 
Mood Disorders in Adolescents 
A systematic review of 18 studies concerning endometriosis in relation to 
psychiatric symptoms found the disease associated with some aspect of reduced mental 
health, quality of life, or type of psychological symptom (Pope, Sharma, Sharma, & 
Mazmanian, 2015). Of those surveyed, 56.4% (44/78) of women with endometriosis had 
symptoms which qualified as a mental disorder, compared to 43.6% (48/110) of healthy 
controls. Based on the findings, it was suggested that women who present with symptoms 
of endometriosis should be screened for psychological disorders (Pope et al., 2015). 
Within mental health disorders, anxiety and depression are the most common comorbid 
diagnoses of endometriosis (Friedl et al., 2015; Laganà et al., 2017; Pope et al., 2015; 
Vitale, Rosa, Rapisarda, & Laganà, 2017). In a review of comorbidities in patients with 
endometriosis, 48% of participants (n=138) had depression and/or anxiety and 35% of 
participants had a mood disorder as well as a comorbid pain condition (Smorgick, Marsh, 
As-Sanie, Smith, & Quint, 2013). Prevalence of mood disorders was highest when 
combined with pain disorders, which although did not include CPP, highlights the 
relationship between mood disorders and chronic pain. The presence of anxiety or 
depression in adolescents diagnosed with endometriosis can reduce their coping 
mechanisms and place them at a disadvantage during the development of CPP (Smorgick 
et al., 2013). Evidence suggests that the presence of mood disorders may increase 
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perception of pain signaling, which then amplifies the cycle of chronic pain development 
associated with disease (Cavaggioni et al., 2014; Laganà et al., 2017). 
 
 
Figure 3: Cyclic relationship between chronic pelvic pain and psychological disease. 
Laganà, A. S., La Rosa, V. L., Rapisarda, A. M. C., Valenti, G., Sapia, F., Chiofalo, B., 
… Vitale, S. G. (2017). Anxiety and depression in patients with endometriosis: impact 
and management challenges. International Journal of Women’s Health, 9, 328. 
 
Mood disorders have been frequently detected among the CPP patient population, 
either as a cause, consequence or simultaneous occurrence (Pereira, França, de Paiva, 
Andrade, & Viana, 2017). The timing of psychological diagnosis as a comorbidity of 
chronic pelvic pain has not been clearly tracked and the question of premorbid 
psychological issues versus those subsequent to chronic pelvic pain still remains 
(Baranowski, 2009). By itself chronic pelvic pain is difficult to diagnose due to the 
subjective nature of symptom perception and similarities to other comorbid conditions, 
especially depression (Pereira et al., 2017). Negative connotation towards mood disorders 
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or the perception thereof within the adolescent population may also present as a limiting 
factor in understanding the mood disorder/CPP relationship. Diagnosis and further 
understanding of mood disorders in relation to CPP should be approached on an 
individual level, gaining an understanding of the patient’s coping mechanisms, rather 
than applying standardized protocol to all presenting patients (Steege & Siedhoff, 2014). 
Cognitive behavioral therapy (CBT) and pharmacotherapy, specifically selective 
serotonin reuptake inhibitors (SSRIs) and benzodiazepines, are standard treatment 
recommendations for adolescents and adults with anxiety and depression. However, 
pharmacotherapy should be utilized only when necessary. Although the National Institute 
of Mental Health concluded in 2007 that the drug benefits outweigh the risks (Bridge et 
al., 2007), SSRIs are known to increase the risk of suicidal thoughts or behavior in 
adolescents. Physical activity has also been used as a therapeutic measure and has shown 
positive outcomes when used among adolescent populations, especially within 
overweight and obese patients (Vancini et al., 2017). Barriers to this treatment option 
include the inability to engage in exercise due to pain symptoms, which limit its 
effectiveness within the target population. Within endometriosis, SSRIs have taken on a 
multifaceted role. As the use of GnRHas for cases of severe endometriosis becomes more 
prevalent in adolescent populations, attention has been taken to the unwanted 
development of anxiety and depression as severe side effects (Warnock, Bundren, & 
Morris, 1998). A study comparing the efficacy of SSRI therapy in conjunction with the 
use of GnRHas showed no improvement in pain scores beyond sole use of GnRHas, 
however, it did show a significant improvement in mental health and suggests the use of 
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SSRIs can help manage side effects of otherwise effective treatment methods (Warnock 





Specific Aims and Objectives 
Chronic pelvic pain plays a critical role in the treatment and management of 
endometriosis, influencing procedure and medication decisions that affect progression of 
disease and patient wellbeing. The aim of this study is to understand the relationship 
between psychosocial factors and the development of chronic pelvic pain in cases of 
adolescent endometriosis. By establishing this relationship, it is then possible to 
investigate the development of central sensitization within this cohort. As central 
sensitization implies heightened nervous system response, it is thought that other 
disorders associated with neurological functioning, including anxiety and depression may 
influence the development of this condition and other comorbid factors.  
 
• Aim 1a: To determine the occurrence of wind-up temporal summation, which is a 
surrogate for central sensitization, in an adolescent and young adult cohort of 
patients with surgically confirmed endometriosis. 
• Aim 1b: To determine if the presence of mood disorders is related to pain 
sensitivity and if it is greater in patients with central sensitization.  
• Hypothesis #1: Participants with diagnosed mood disorders will have greater pain 
sensitivity, lower pain thresholds, and a higher occurrence of central sensitization 
compared to participants without mood disorders. 
 
• Aim 2: To compare quality of life and pre-surgical pain catastrophizing measures 
in patients with endometriosis to determine whether the presence of central 
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sensitization and/or mood disorders impacts quality of life and pain 
catastrophizing. 
• Hypothesis #3: The presence of anxiety, depression and central sensitization in 
patients with endometriosis will be higher in those demonstrating pre-surgical 









This study was conducted by the Biobehavioral Pediatric Pain Lab (BPPL) at 
Boston Children’s Hospital (BCH), in conjunction with the Boston Center for 
Endometriosis (BCE), and looked to identify the presence of central sensitization in 
adolescent and young women diagnosed with endometriosis. Participants were women 
enrolled in the Women’s Health Study: From Adolescence to Adulthood (A2A), a 
prospective, longitudinal study through the BCE that conducts deep phenotyping of 
endometriosis. All patients enrolled in A2A are evaluated by and operated on the BCE, 
thus the participants in this study received diagnosis confirmation and follow-up 
treatment of endometriosis by the same physician, director Dr. Marc Laufer.  
 
Recruitment 
• Participation in the study is based on multiple factors and recruitment uses IRB-
approved techniques to enroll subjects. Eligible women must be enrolled in the 
BCE’s Women’s Health Study: from Adolescence to Adulthood program, be 
between the ages of 14 and 22, and have a diagnosis of endometriosis (confirmed 
via laparoscopic investigation). Potential participants presented to either the 
outpatient clinic in the Department of Gynecology and Adolescent Medicine at 
Boston Children’s Hospital in Boston or outpatient offices at Boston Children’s at 
Lexington. Prior to clinic arrival, research assistants at the BCE screened patients 
enrolled in the A2A program for eligibility in this study. BPPL research interns 
approached potential participants upon checking into the clinic to obtain initial 
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consent and assent from interested patients and parents, when applicable. In the 
case of a schedule conflict with an interested patient, BPPL contact information 
was given and patients received a follow-up phone call to schedule a time to 
participate in the study.  
 
Measures 
Pre-surgical Baseline Survey  
• All participants of the Women’s Health Study: A2A are asked to complete a 
baseline survey provided by the BCE upon enrollment. With the purpose of 
collecting information to generate symptomatic changes among participants, the 
baseline survey was completed by 45 of the 46 total participants in the study 
before undergoing a laparoscopic procedure for confirmation of endometriosis. 
Participants completed the survey at home or during a visit to BCH or Brigham 
and Women’s Hospital (BWH), and were given the option to use a 
tablet/computer or to complete via written questionnaire. The baseline survey has 
been amended multiple times since its creation, due to the longitudinal nature of 
A2A and desire for questions that provide current information. Several versions of 
the survey were used by study participants and careful consideration was taken 
when retrieving responses to specific prompts to ensure accuracy across the 
cohort. Unfortunately, this variation also led to incomplete data collection. The 
baseline survey contains a series of questions regarding participant demographics, 
menstruation and reproductive history, pelvic pain and pain associated with 
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menstruation, medical and family history, lifestyle choices and sun exposure. 
Questions from the 36-Item Short Form Health Survey (SF-36), a questionnaire 
designed to measure health and wellbeing from the patient’s point of view, were 
also used to gauge participant quality of life.  
• Short Form Health Survey (SF-36): Developed by RAND Corporation, the SF-36 
is a generic series of questions intended to provide details on one’s quality of life 
as a way to measure patient outcomes and treatment efficacy (J. E. Ware & 
Sherbourne, 1992). Due to its self-reporting nature, the SF-36 was developed to 
be a logical series of situations grouped by presenting scenario to be answered 
using a numerical scale. The eight categories highlighted in the SF-36 include 
physical abilities (e.g. “How does your physical health limit you from bending, 
kneeling or stooping?”), limitations due to physical health (e.g. “Were you limited 
in the kind of work or other activities as a result of your physical health?”), 
limitations due to emotional health (e.g. “During the past four weeks, to what 
extent has your physical health or emotional problems interfered with your 
normal social activities with family, friends, neighbors or groups?”), presence of 
pain (e.g. “How much physical pain have you had in the past four weeks?”), 
emotional wellbeing (e.g. “During the past four weeks, have you been a very 
nervous person?”), social interactions and limitations (e.g. “During the past four 
weeks, how much of the time has your physical health or emotional problems 
interfered with your social activities?”), general health comprehension (e.g. “How 
true or false are the following statements to you: I seem to get sick a little easier 
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than other people, My health is excellent, etc.”) and energy/fatigue levels (e.g. 
“During the past four weeks, did you feel worn out?”), as well as a prompt to 
gauge individual understanding of health progression (“Compared to one year 
ago, how would you rate your health in general now?”) (J. Ware, Snoww, MA, & 
BG, 1993). To score the completed form, the eight categories are scaled and 
calculated into numbers from 0 to 100, with a lower value indicating greater 
disability (0 correlates to maximum disability, 100 to no disability present). The 
survey is widely used within clinical research and health policy evaluations, as 
well as general population surveys (J. E. Ware & Sherbourne, 1992). 
• Pain Catastrophizing Scale (PCS): Developed by Michael JL Sullivan, Ph.D., the 
pain catastrophizing scale is a series of 13 questions to allow research of 
catastrophizing behaviors related to pain experiences. The data can be translated 
into three subsets: rumination (“I can’t stop thinking about how much it hurts”), 
magnification (“I worry that something serious may happen”) and helplessness 
(There is nothing I can do to reduce the intensity of the pain”) (Sullivan, 2009). 
Incorporated within the A2A baseline survey, participants are asked to rate the 
degree to which they experienced each thought or feeling on a five-point scale 
from 0 (not at all) to 4 (all the time). The questions are divided between the PCS 
categories and the summation of each is used to determine significance. PCS 
scores allow providers to gain insight into the coping methods their patient 
utilizes for chronic pain. Understanding the manner in which an individual 
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responds to a pain condition can aid in treatment development and long-term care 
planning.  
• Medical History: In addition to information regarding symptoms related to the 
menstrual cycle and pain perception, the baseline survey provides a thorough 
review of individual medical history. This includes questions regarding 
acne/pimples, bodily hair growth, and prior surgical encounters. Of interest to this 
study, the medical history section of the baseline survey also reviews possible 
comorbid conditions including asthma, diabetes, thyroid disorders, fibromyalgia, 
migraines, gastroesophageal reflux disease, cancer and mood disorders, which are 
separated into questions specific to anxiety disorder, depression/mood disorder, 
eating disorder, and attention deficit disorder. When prompted with “Have you 
ever been told by a doctor that you have any of these conditions?”, a positive 
confirmation then prompts the participant to detail age of diagnosis and any 
medications they have taken for more than three months within the past year. 
Review of medical history information provided the framework for further 
investigation into the presence of mood disorders within the study cohort.  
 
Pain Sensitivity Questionnaire 
• Participants were asked to complete the Pain Sensitivity Questionnaire (PSQ), a 
series of seventeen situational questions to be answered using a numerical scale. 
All questions present a scenario that may elicit pain and ask the participant to rate 
their perceived pain level from 0 to 10 (0 = not painful at all, 10 = most severe 
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pain imaginable). Of the seventeen questions, three are not considered painful by 
healthy subjects (Azimi & Benzel, 2016). Only whole-number answers are 
recorded. Individuals are asked to focus on pain perception and avoid feelings of 
fear or aversion to proposed situations. Examples of PSQ scenarios include 
“Imagine you have grazed your knee falling off your bicycle”. First developed in 
German, the PSQ has been adapted to the English language with similar success 
(Sellers, Ruscheweyh, Kelley, Ness, & Vetter, 2013). The questions are scored 
into two categories: PSQ-minor, which takes the average response of seven 
questions deemed to elicit minor levels of pain in a healthy individual, and PSQ 
moderate, which does the same for seven questions presumed to generate 
moderate pain levels (Ruscheweyh et al., 2012). PSQ score analysis allows further 
understanding of perceived pain levels compared to healthy baseline values.  
Quantitative Sensory Testing 
• For the physical portion of the protocol, patients participated in a version of 
Quantitative Sensory Testing (QST), a noninvasive assessment of sensory 
detection and threshold (Cornelissen et al., 2014). Developed to assess large and 
small nerve fiber function related to pain in the research setting, QST can 
determine thresholds of thermal, mechanical touch and vibration across the body. 
Pain sensation from mechanical, thermal or deep pressure can also be assessed at 
various body sites (Cornelissen et al., 2014). In addition to recording sensation 
and pain thresholds, QST can also be used to measure temporal summation, or the 
sensory detection by a single stimulus. For this test, one QST measure is 
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repeatedly applied to the same test site and sensation or pain detection is recorded. 
Temporal summation can detect the presence of a wind-up phenomenon, where a 
repeated application of the same stimuli produced increased levels of sensation. In 
this study, mechanical detection and mechanical and pressure thresholds as well 
as wind-up temporal summation QST was used. All study parameters were first 
applied to the control site (deltoid muscle for mechanical, thumbnail for pressure) 
before abdominal administration to the four quadrants (upper left, upper right, 
lower left, lower right). The study protocol included the following: 
• Touch and sharpness sensations were determined using Von Frey hairs. 
Developed in 1896 by Maximilian von Frey, these hairs are a type of 
aesthesiometer designed to detect light touch sensation and are comprised 
of plastic filaments of increasing diameter (Fruhstorfer, Gross, & 
Selbmann, 2001). For each level of sensation, the participant was asked to 
rate any pain on a numerical scale from 0 to 10. 
• Touch sensation level was determined by the repeated application 
of Von Frey hairs in increasing diameter until sensory detection 
was confirmed via repeated blind stimulation.  
• Sharpness threshold was recorded using the same process, with the 
participant indicating the sensation of a ‘sharp prick’ or ‘a needle’ 
through multiple (2 out of 3 trials) blind administrations.  
• Temporal summation was determined using the Von Frey hair 
producing the sharpness threshold through repeated application, 
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with the pain rating recorded for each. The presence of wind-up 
phenomenon served as a surrogate for central sensitization. 
 
Figure 5: Von Frey Filaments.  (A) Represents original Von Frey drawing where W 
represents the filament and F identifies dermal site of application. (B) Represents an 
illuminated filament. (W) refers to the filament, (F) to the dermal test site. Fruhstorfer, 
H., Gross, W., & Selbmann, O. (2001). von Frey hairs: new materials for a new design. 
European Journal of Pain (London, England), 5(3), 341–342.  
 
 
o Pressure sensation was determined using an algometer on the thumbnail 
(control site) and abdominal quadrants. Participants were asked to indicate 
when they experienced discomfort, at which point the applied pressure 
level was recorded. Each site was tested three times, after which an 




Medical Chart Review 
● In addition to information collected from the baseline questionnaires, medical 
chart review was performed on all participants with the purpose of confirming the 
diagnosis of anxiety, depression or other mood disorder. The reasoning for further 
review of patient medical history was due to the self-reporting nature of the A2A 
baseline survey and possibility for mis- or underreporting mood disorder 
diagnoses. Charts were reviewed to collect presence of mood disorder diagnosis 
and, if present, type of disorder, number of current medications (with current 
defined as the date of or most recent clinic appointment prior to participation in 
the study), types of medication if applicable, and family history of endometriosis 





In total, the cohort contains 48 participants ranging in age from 14 to 22 
(mean=17.65, SD=1.91), who are all residents of the greater Boston area and enrolled 
either in middle school, high school or undergraduate coursework. The age of first 
menarche ranged from 10 to 15 years old (mean=11.51, SD=1.30) and stage of 
endometriosis ranged from I to II based on the ASRM classification scale performed by 
Dr. Marc Laufer at BCH. Dr. Laufer performed all diagnostic laparoscopic procedures 
and initiated similar treatment protocols to all participants. The participation in QST was 
between 19 and 1685 days (M=4.61 years, SD=1.33 years) from the date of first surgery. 
Comparing date of surgery to time of QST participation, the reported pain at QST was 
related to days since surgery and showed lower pain levels correlated to a higher number 
of days since surgery. Further demographic information about the participants is provided 





Of the 48 participants, 20 had confirmed mood disorder diagnoses (+MD) of 
either anxiety or depression treated with prescription medication at time of study 
participation. Of the 20 confirmed diagnoses, 12 self-reported their diagnosis on the A2A 
baseline questionnaire and 8 were collected during a cohort-wide medical chart review. 
All 20 +MD subjects presented with anxiety and 12 were receiving additional treatment 
for depression. Treatment ranged from one (n=14) to three (n=1) prescription 
medications and a total of 9 different medications were used within the cohort, the details 
of which are listed in Table 2. The most common form of pharmacotherapy was a 
selective serotonin reuptake inhibitor (SSRI) (n=18), followed by a serotonin 
norepinephrine reuptake inhibitor (SNRI) (n=2). 
Table 1: Demographic Information 
 Frequency 
(Range, Mean, [Standard Deviation]) 
Age of Participant on DOS 14-22, 17.65, [1.91] 
Age of First Menstrual Period 10-15, 11.51, [1.30] 
Days between DOS and QST  19-1,685, 651.08, [486.08] 
 Frequency Percent 
Race of Participant (n=45)   
 White 36 75.0 
 “Spanish/Hispanic/Latina” 3 6.3 
 Black/African American 2 4.2 
 Other 4 8.3 
Current Education Status (n=44)   
 Middle School 2 4.2 
 High School 34 70.8 
 College 8 16.8 
Current work status (n=42)   
 Full time student 36 75 
 Working in paid job as employee 3 6.3 
 Unable to work 1 2.1 




Table 2: Types of Prescription Medications for the Treatment of Anxiety and 
Depression within the Cohort  
 
Type of Medication Generic (Brand) # of Participants 
SSRI Fluoxetine (Prozac) 9 
SSRI Citalopram (Celexa) 4 
SSRI Sertraline (Zoloft) 3 
Benzodiazepine Clonazepam (Klonopin) 3 
SNRI Venlafaxine (Effexor XR) 2 
Benzodiazepine Lorazepam (Ativan) 2 
SSRI Escitalopram (Lexapro) 1 
 
Quantitative Sensory Testing Analysis 
 Aim 1a: To determine the occurrence of wind-up temporal summation, which is a 
surrogate for central sensitization, in an adolescent and young adult cohort of patients 
with surgically confirmed endometriosis. 
 The cohort was evaluated for the presence of wind-up, considered a surrogate of 
central sensitization, using the temporal summation and sharp prick pain scores recorded 
during QST. Using a calculated ratio between average temporal summation and 
mechanical stimulation threshold pain ratings, a score above 0.33 (or 33%) indicates the 
presence of central sensitization through wind-up phenomenon. Of the 48 participants, 23 
received scores above 0.33 and were determined to have presented with central 
sensitization (47.9%). 25 participants (52.1%) were determined to not have wind-up, and 
therefore did not have central sensitization. Within the group with central sensitization 
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(+CS), 18 subjects presented with wind-up of the lower abdomen, 15 in the upper 
abdomen, 21 in the abdomen only, three in the deltoid only and nine presented with 
systemic presence of wind-up (lower and upper abdomen, deltoid). Detailed analysis is 
found in Table 2. Bivariate Pearson correlations were used to assess relationships 
between QST measures and central sensitization. Wind-up of the upper abdomen was 
positively correlated with lower abdomen wind-up (r=0.60, p<0.01). Average pressure 
ratings from the finger positively correlated to average pressure ratings of the upper 
abdomen (r=0.60, p<0.01) and lower abdomen (r=0.59, p<0.01). Average pressure ratings 
of the upper and lower abdomen were also significantly correlated (r=0.88, p<0.01). 
 





Wind-up in the 
upper abdomen















pain of the 
finger
Central Sensitization
Wind-up in the upper 
abdomen
Wind-up in the lower 
abdomen
Average pressure sensation 
and pain in the upper 
abdomen
Average pressure sensation 
and pain in the lower 
abdomen
Average pressure sensation 
and pain of the finger
1 .613** .808** .008 .009 .068
.000 .000 .956 .952 .648
48 48 48 48 48 48
.613** 1 .592** -.097 -.161 -.123
.000 .000 .514 .274 .405
48 48 48 48 48 48
.808** .592** 1 .008 -.032 .125
.000 .000 .955 .831 .397
48 48 48 48 48 48
.008 -.097 .008 1 .876** .601**
.956 .514 .955 .000 .000
48 48 48 48 48 48
.009 -.161 -.032 .876** 1 .586**
.952 .274 .831 .000 .000
48 48 48 48 48 48
.068 -.123 .125 .601** .586** 1
.648 .405 .397 .000 .000
48 48 48 48 48 48




 Paired t-tests for wind-up measures showed a significant difference between 
pressure ratings of the finger (M=33.7, SD=19.05) and average pressure ratings of the 
upper abdomen (M=13.33, SD=5.16), T(48)=8.57, p<0.001; as well as with lower 
abdomen pressure (M=13.65, SD= 6.33), T(48)=8.59, p<0.001, indicating that the 
pressure thresholds in the abdomen area for this sample were lower compared to the 
finger. 
 
Aim 1b: To determine if the presence of mood disorders is related to pain sensitivity and 
if it is greater in patients with central sensitization. 
 To examine the relationship between central sensitization and mood disorder 
diagnosis within the cohort, a cross tabulation of the data was performed. Of the 20 
subjects with confirmed mood disorder diagnoses (+MD), 12 were within the +CS group 
(60%) and 8 identified as -CS (40%). As part of the +CS group, +MD subjects 
represented 57.1% of all cases of wind-up. For depression, cross tabulation between the 
12 identified subjects and central sensitization showed equal distribution across the +/-CS 
groups with six subjects in each (50%). Participants with depression represented 28.6% 
of the +CS group. Of note, all participants with diagnoses of depression also presented 
with confirmed anxiety disorder. Neither the relationship between anxiety and central 







Table 4: Anxiety and Depression as related to Central Sensitization 
 
 The relationship between anxiety and wind-up presentation was examined. Using 
one-way analysis of variance (ANOVA), a positive correlation between anxiety and 
wind-up in the abdomen (M=0.33, p<0.05) was found.  
 
  
Table 4: Anxiety and Depression as related to Central Sensitization 
 +CS or -CS 
No Yes 
Anxiety No Count 17 9 
 
 
% within +CS or -CS 68.0% 42.9% 
Yes Count 8 12 
 
 
% within +CS or -CS 32.0% 57.1% 
Total Count 25 21 
 +CS or -CS 
No Yes 
Depression No Count 19 15 
 
 
% within +CS or -CS 76.0% 71.4% 
Yes Count 6 6 
 
 
% within +CS or -CS 24.0% 28.6% 








Emotional Wellbeing Within the Cohort 
Aim 2: To compare quality of life and pre-surgical pain catastrophizing measures in 
patients with endometriosis to determine whether the presence of central sensitization 
and/or mood disorders impacts quality of life and pain catastrophizing. 
Using one-way analysis of variance (ANOVA), a positive correlation between 
anxiety and finger pressure pain (M=0.32), p<0.05), was found. For wind-up scores, a 
positive correlation was found between deltoid wind-up and pre-operative pain scores 
(M=0.30, p<0.05), rumination (M=0.42, p<0.05) and pain catastrophizing (total score) 
(M=0.37, p<0.05). 
 One-way ANOVA was also used to identify potential differences between the 
+CS and -CS groups in regards to pre-surgical pain catastrophizing. Pain Catastrophizing 
Central 
Sensitization Anxiety Depression






Wind-up in the abdomen 
(lower or upper)
1 .253 .052 .835**
.090 .732 .000
48 46 46 48
.253 1 .677** .333*
.090 .000 .024
46 46 46 46
.052 .677** 1 .105
.732 .000 .488
46 46 46 46
.835** .333* .105 1
.000 .024 .488
48 46 46 48
Correlation is significant at the 0.01 level (2-tailed).**. 




Scale measures of helplessness, rumination and magnification were reviewed for 
significance. Although there were no significant differences between the two groups on 
pre-surgical pain and pre-surgical pain catastrophizing, the +CS group showed clinically 
significant rumination (M=11.17, SD=6.41) and the entire sample demonstrated clinically 
significant feelings of helplessness (M=13.26, SD=6.41) (Sullivan, 2007). 
Participants were asked to rate recent pain experiences during QST 
administration. Worst pain the last six months was negatively correlated to average 
pressure ratings of the finger (r=-0.57, p<0.01). Pre-operative pain scores were recorded 
from A2A surgical forms and medical chart review. Pre-operative pain was significantly 
correlated with PCS subscales of rumination (r=0.48, p<0.01), magnification (r=0.44, 
p<0.01), and PCS total score (r=0.44, p<0.01).  
One-way ANOVA was used to compare the PSQ total and subscale scores of the 
sample to published healthy control means. There was found to be a significant difference 
between PSQ minor sub-score for the sample (M=2.9, SD=1.37), and the healthy control 
(M=2.5, SD=+/-1.1); t(48)=2.09, p=0.04, indicating that the present sample is bothered 
more by minor sensory stimuli.  
Significant correlations were found when comparing pre-operative pain and pain 
catastrophizing measures from PCS across the cohort as a whole. Pre-operative pain was 
significantly correlated to PCS total score (r=0.44, p<0.01), magnification (r=0.44, 
p<0.01) and rumination (r=0.48, p<0.01). No significance was found between pre-




Table 6: Correlations (r) between Anxiety Dimensions and Functional Disability 
 
Table 7: Correlations between QST Measures, Pre-surgical Pain and Pain 

















1 .480** .438** .336 .444**
.004 .009 .052 .008
47 34 34 34 34
.480** 1 .674** .817** .926**
.004 .000 .000 .000
34 34 34 34 34
.438** .674** 1 .684** .820**
.009 .000 .000 .000
34 34 34 34 34
.336 .817** .684** 1 .952**
.052 .000 .000 .000
34 34 34 34 34
.444** .926** .820** .952** 1
.008 .000 .000 .000
34 34 34 34 34













"In the last six 
months, what 







Wind-up in the deltoid
Average pressure sensation 
and pain of the finger
Pre-surgical pain score
"In the last six months, what 
was your worst pain?"
PCS - rumination
PCS total score
1 .669** .068 .034 .116 .246 .227
.000 .648 .820 .590 .161 .197
48 48 48 47 24 34 34
.669** 1 -.221 .303* .206 .423* .370*
.000 .131 .038 .334 .013 .031
48 48 48 47 24 34 34
.068 -.221 1 .008 -.566** -.202 -.103
.648 .131 .960 .004 .251 .562
48 48 48 47 24 34 34
.034 .303* .008 1 -.139 .480** .444**
.820 .038 .960 .528 .004 .008
47 47 47 47 23 34 34
.116 .206 -.566** -.139 1 -.127 -.191
.590 .334 .004 .528 .639 .479
24 24 24 23 24 16 16
.246 .423* -.202 .480** -.127 1 .926**
.161 .013 .251 .004 .639 .000
34 34 34 34 16 34 34
.227 .370* -.103 .444** -.191 .926** 1
.197 .031 .562 .008 .479 .000
34 34 34 34 16 34 34
Correlation is significant at the 0.01 level (2-tailed).**. 






 This study seeks to identify the relationship comorbid factors play in the 
development of chronic pelvic pain with endometriosis. The results of the reviewed 
variables show no significant relationship between the presence of anxiety or depression 
with central sensitization or pain catastrophizing. Although the data contradicted the 
proposed hypotheses there is a need for great consideration as to why the results 
presented opposite to what was expected. Post-hoc analysis of data variables presented 
several points for discussion when considering the results, study limitations and future 
directions.  
 
Hypothesis 1: Participants with diagnosed mood disorders will have greater pain 
sensitivity, lower pain thresholds, and a higher occurrence of central sensitization 
compared to participants without mood disorders. 
 The cohort was moderately split between participants with and without central 
sensitization. Within the measures of QST, the correlation between average pressure 
sensation and pain scores of the finger, upper abdomen and lower abdomen imply 
positive relationships between test sites regarding deep pressure pain sensation. Lower 
and upper abdomen wind-up threshold correlation shows even pain distribution within 
the sample, rather than quadrant-specific pain sensitivity, which is in line with the 
development of CS and is to be expected (Melzack & Katz, 2012). Compared to pilot 
data for this sample from 2017, the rate of wind-up phenomenon has increased from 24% 
to 47.9% within the cohort (Resad, 2017). One point of note from the QST data was the 
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presence of wind-up phenomenon only at the deltoid control site for three participants. 
This data presentation was determined to fall into the category of central sensitization 
even though it was not detected at the abdominal test sites and suggests central 
generalization of sensory input that is not correlated with assumed anatomical regions for 
CS with CPP. This spread of pain sensitivity specific to central sensitization was 
demonstrated through the use of nerve blocks to isolate pain sensation, however the 
mechanism and duration of migrating sensation has been debated (Woolf, 2011). 
Continued research as the sample grows will allow further understanding of this 
phenomenon.  
 The only significant relationship found between +MD and central sensitization 
was between anxiety and wind-up threshold of the abdomen, highlighting a relationship 
between anxiety and heightened mechanical touch sensitivity within the cohort. No other 
significant relationship was found between mood disorder diagnosis and presence of 
central sensitization. Occurrence of +MD was almost equally split between +CS and –CS 
groups (see Table 3). As the results go against the proposed hypothesis, several theories 
have been proposed for the reasoning behind the equal distribution and lack of 
significance within the +MD group including the extensive use of pharmacotherapeutics 
within the sample. 
 
Pharmacotherapy for Comorbid Symptoms 
In this cohort, all participants with a diagnosed mood disorder were being treated 
by a prescription medication, however, only 10% of the +MD subgroup was treated with 
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an SNRI (versus SSRI). To date, there is not enough data to support the use of SNRIs 
versus SSRIs in cases of adolescent major depressive disorder and, as of 2016, SNRI 
medications are not recommended by the FDA as first line therapy (Garland, Kutcher, 
Virani, & Elbe, 2016). Given this information, it is understandable why the majority of 
+MD study subjects are being treated with SSRIs. However, when looking at mental 
health as a comorbid condition to endometriosis, especially in cases including chronic 
pelvic pain, only using symptoms of anxiety and depression when determining 
pharmacotherapeutic regimen does not adequately address the overall symptom 
presentation. Consideration should be taken for secondary effects of available 
medications that could alleviate primary symptoms of endometriosis, including pelvic 
pain. 
The standard treatment for depression and some anxiety in adolescent and adult 
populations, SSRI and SNRI drugs have also been trialed in chronic pain populations for 
the purpose of reducing pain symptoms. Although results for SSRI use for chronic pain in 
adolescents have been inconclusive (Patetsos & Horjales-Araujo, 2016), the positive 
effects of SNRI medications for pain reduction have been shown in studies on adult 
subjects (Obata, 2017). SNRIs are able to dampen pain signaling through the inhibition of 
norepinephrine reuptake in the dorsal horn of the spinal cord. By binding to ⍺2-adrenergic 
receptors and preventing a cellular signaling cascade, SNRIs hyperpolarize the cell 
membranes and prevent the release of excitatory neurotransmitters from primary afferent 
fibers (Obata, 2017). Of note, although this inhibitory mechanism is effective against 
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allodynia and hyperalgesia, it does not provide adequate pain reduction for noxious 
stimuli (Obata, 2017).  
 It is also possible to use SSRIs for the reduction of side effects brought on by 
GnRHas in cases of severe endometriosis, and should be considered as adolescents 
mature and utilize GnRHa therapy as adult patients. Further research should be 
performed to look at the relationship between endometriosis, chronic pelvic pain, mood 
disorders and the efficacy of SSRI and SNRI medications on the symptoms presenting 
from these comorbid conditions.  
 
Hypothesis 2: The presence of anxiety, depression and central sensitization in patients 
with endometriosis will be higher in those demonstrating pre-surgical pain 
catastrophizing and will negatively relate to quality of life measures. 
 Scores collected from pre-surgical forms and visits to the BCH clinic showed a 
positive correlation to PCS total score, as well as the subsets of rumination and 
magnification. This describes the sample as one with high levels of pain and 
catastrophizing behaviors before surgical intervention for endometriosis. This 
relationship is anticipated in cases of chronic pain (Miller & Kaiser, 2018). Pre-surgical 
pain scores also correlated to wind-up phenomenon in the arm, which although 
unexpected, proposes a heightened awareness of input by the nervous system only at the 
start of QST due to the failure of correlation by abdominal wind-up variables. More in 
line with expected norms, average pressure sensation and pain scores for the arm were 
positively correlated with pain scores in response to the question ‘In the past six months, 
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what was your worst pain?’ which was asked at the time of QST participation. This 
relationship indicates a decreased pain threshold and increased pain awareness within the 
cohort.  
 PCS total score and the subset measures of helplessness and rumination were 
significantly correlated to wind-up variables and highlight a strong relationship between 
the presence of central sensitization and pain catastrophizing. This relationship can be 
explained by the adaptation by the nervous system during development of CS to 
generalize incoming stimuli, which is similar to the thought generalization that occurs 
during catastrophizing behavior (Sullivan, 2009). The tendency to overreact and remain 
at a heightened level of sensitivity to incoming stimuli – whether that may be mechanical 
or cognitive – is found in both phenomena.  
 Represented by the PCS helplessness and PSQ minor variables, clinically 
significant levels of pain catastrophizing were identified throughout the sample. Both 
categories produced clinically significant values for both +CS and –CS groups, indicating 
the universal presence of helplessness and increased pain sensitivity to situations deemed 
slightly painful compared to healthy controls and standard clinical values. These results 
highlight the impact endometriosis and comorbid conditions have on the adolescent 
population and propose the investigation into the source of helplessness and pain 
sensitivity. One potential source, parental support, has been highlighted as a factor in 
child functioning in cases of chronic pain, and endometriosis being a hereditary disease 




Endometriosis: A Hereditary Disease 
 For cases of chronic pain within the adolescent population, parent involvement 
plays a definitive role in treatment outcomes and recovery, and chronic pain conditions 
frequent impact the entire family unit (Sieberg, Williams, & Simons, 2011). Parents are 
likely to have an emotional response to their child’s pain, which can impact their own 
psychological response to the condition and influence child functioning (Sieberg et al., 
2011). Ineffective responses by parents to their child’s pain, including reassurance, 
solicitous, and protective parenting behaviors, increase the likelihood of adverse 
outcomes in both clinical pain (Claar, Simons, & Logan, 2008) and experimentally 
induced pain populations (Walker et al., 2006). When looking specifically at parent 
distress in relation to child functional disability, Sieberg et al. determined that all 
examined variables (helplessness, parent depression, anxiety, and catastrophizing) were 
significantly correlated to child functional disability (Sieberg et al., 2011). This study 
showed a relationship between parental variables and child functional disability, which 
was partially mediated by parent protectiveness. Although parent protectiveness in 
response to child pain is common, their actions do not correlate with improved pain 
outcomes (Connelly et al., 2010). 
As a hereditary condition, the growth of endometrial lesions can be predicted as 
adolescents reach puberty and experience similar pain symptoms to older relatives with 
the disease. The unique relationship between generations of women within a family in 
regards to pathological symptoms and treatment could easily magnify the results of 
parent protective responses. In addition to presenting the common parental responses of 
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protectiveness, involved family members with a history of endometriosis share personal 
experiences with similar pain symptoms, which could lead to higher pain responses by 




Limitations of the study should be addressed. Most noticeable is the small sample 
size of which this data was collected from. Participants were recruited at follow-up 
outpatient appointments where time constraints due to travel or other appointments were 
often the barrier between consent and refusal. Visit length was frequently longer than 
scheduled, but while this prevented patients from participating, the reason for the 
appointment is the primary concern and should not be neglected for research purposes. 
Expanding the recruitment locations to outpatient clinics both in Boston and Lexington, 
Massachusetts allowed more opportunity for patient enrollment. Further participation 
incentive through parking validation was implemented in February 2018.  
Additionally, it is important to note that over the course of 48 patients, five 
different members of the BPP lab performed QST. While all members were fully trained 
on the study protocol, the possibility of personal bias when presenting the protocol should 
be considered. Training continuity and familiarization with the study protocol in the 
future may reduce the impact this limitation has on data collection. Of note, for the three 
patients presenting with deltoid-only wind-up, different test administrators were cited for 
each, all at different stages of protocol experience, suggesting no connection between 
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unexpected CS results and administrator error. To date, any evidence within the data set 
of operator error has not presented as so.  
Another possible limitation of this study concerns participant doubt with protocol 
progression. The use of Von Frey filaments requires the participant to state when they 
feel the sensation of a “needle or sharp prick” as filament diameter is increased from their 
level of sensation. Participants are instructed prior to Von Frey application to alert the 
researcher if any pain is detected. The wording, along with the concept of identifying a 
strong feeling just prior to pain sensation, may elicit premature declaration of a “needle 
or sharp prick” sensation. Temporal summation of the filament determined to illicit this 
sensation commonly produced statements of doubt from participants, bringing to light the 
possibility of suggested sensation misinterpretation. This could prevent the detection of 
central sensitization by using a Von Frey filament too small in diameter to propagate the 
appropriate pain threshold response. Further education on the purpose of the filaments 
could alleviate this possible limitation.  
Participants may also report low levels of pain during QST due to comparison of 
pain experienced from endometriosis and CPP symptoms. In an effort to demonstrate the 
severity of cyclic pain symptoms, subjects may underreport pain sensation produced 
during QST. The collection of recent pain ratings prior to QST administration (‘What is 
your current pain rating?’, ‘What was your worst pain rating in the past three weeks?’, 
etc.) may help validate reports of severe pain symptoms by participants, however these 
scores were not collected for the first 20 subjects in the cohort. 
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 The time between day of surgery (DOS) and date of QST administration ranged 
from 19 to 1685 days (mean = 651 days). This suggests a few implications within the 
data set. First, for women who underwent QST within a month of surgery, lower pain 
scores may have been reported due to lack of a complete menstrual cycle post-lesion 
resection. As endometrial lesions develop with rising estrogen levels, the lack of a 
complete cycle may prevent any new lesion growth. Without further disease progression 
and current presence of pelvic pain symptoms, QST data may not be able to detect 
presence of wind-up at time of participation. A review of pain scores from QST versus 
DOS could aid in understanding the development of pain symptoms for patients with 
short DOS/QST timeframes. Second, the mean number of days from DOS to date of QST 
was about 21 months. Extensive time between DOS and QST allows for disease 
development and progression that is not tracked by this study. Participants may have 
received additional procedures to remove endometrial lesions, which would weaken the 
relationship between DOS and QST pain scores. Working with an adolescent population, 
developmental gains are likely to occur between completion of the baseline questionnaire 
and date of QST. As the cohort matures, their comprehension of the disease and pain 
management, including pain catastrophizing, evolves. Follow up surveys with similar 





 The next step for this study is to establish a control sample for the comparison of 
QST values. The control group will undergo thermal imaging of the pelvic region in 
addition to current study measures (QST and PSQ).  
 Currently participants are recruited from the Women’s Health Study, which will 
terminate enrollment in June 2018. Although not all A2A participants are also enrolled in 
this study, the completion of patient recruitment for A2A decreases administrative 
support for further enrollment towards this ongoing project. Efforts to recruit from other 
studies in the future are ongoing. The continuation of A2A after enrollment completion 
will be in the form of follow up surveys and longitudinal tracking of participants. The 
addition of post-hoc surveys to further understand the mental health profile of all A2A 
participants would allow better understanding of pain development in patients with these 
comorbid conditions. 
 The current data review was limited by the validity and detail of mood disorder 
diagnosis, as all information came from self-reported baseline questionnaires and medical 
chart review. Follow up surveys for study participants including specific measures of 
mental health would more accurately define the cohort. This would also allow researchers 
to screen all participants, not just those with records of diagnoses of anxiety and 
depression, for a range of mental health disorders. Possible tools include the Children’s 
Depression Inventory (CDI) or the Hospital Anxiety and Depression Scale (HADS) for 
depression, and the Youth Anxiety Measure (YAM-5) or Kutcher Generalized Social 
Anxiety Scale for Adolescents (K-GSAS-A) for the presence of anxiety.  
	
45 
As an ongoing study, further investigation of the relationship between endometriosis, 
CPP, mental health, pre-surgical pain catastrophizing and the development of CS within 
the adolescent population are encouraged. The collection of additional participant data 
from A2A longitudinal progression analysis, subsequent surgical documentation and 
participation in thermal QST measures will all positively contribute to the success of this 
study. The effect of mental health and pain catastrophizing on adolescents with 
endometriosis is clearly connected to the presence of CPP and CS development. Defining 
these relationships and developing strategies for early detection and intervention can 
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